Depression

Targeted PGx Testing Found Actionable Depression Drug-Gene Results

by
Targeted PGx Testing Found Actionable Depression Drug-Gene Results

TL;DR: A 2026 study in The Pharmacogenomics Journal tested pharmacogenomic (PGx) depression care, meaning medication guidance based on drug-gene interactions; targeting Veterans already taking antidepressants with common PGx interactions raised the actionable-result rate to 30%, but immediate test-result access did not improve Patient Health Questionnaire-9 (PHQ-9) depression scores over 12 weeks. Key Findings 60 Veterans …

Read more

Morganella Phospholipids Linked Gut Bacteria to Depression

by
Morganella Phospholipids Linked Gut Bacteria to Depression

TL;DR: A 2025 study in Journal of the American Chemical Society found that a depression-linked gut bacterium now has a concrete inflammatory mechanism: Morganella morganii can make unusual phospholipids that activate TLR2/TLR1 and drive IL-6. Key Findings Morganella got a molecule: The paper moved beyond a microbiome correlation by isolating pro-inflammatory metabolites made by M. …

Read more

Psychedelic Treatment Media Coverage Used More Positive Tone

by
Psychedelic Treatment Media Coverage Used More Positive Tone

TL;DR: A 2026 Scientific Reports study of 6,805 English-language media reports found that psychedelic-treatment coverage for depression and PTSD used more positive tone than antidepressant coverage, while antidepressant coverage used more risk and negative-emotion language. Key Findings 6,805 media reports: Researchers analyzed English-language newspaper coverage from 2017 to 2024 using LexisNexis and natural language processing. …

Read more

Esketamine PTSD Flashbacks Usually Faded in Treatment-Resistant Depression Case Series

by
Esketamine PTSD Flashbacks Usually Faded in Treatment-Resistant Depression Case Series

TL;DR: A 2026 retrospective case series study in European Journal of Psychotraumatology found that trauma flashbacks during esketamine nasal spray sessions were distressing but usually time-limited in 22 patients with treatment-resistant depression and PTSD; when treatment continued, depression response was 45.5% and PTSD improvement was 45.5%. Key Findings 22-patient case series: Researchers reviewed adults with …

Read more

Electroacupuncture for Depression Needs Biomarker-Guided Trials

by
Electroacupuncture for Depression Needs Biomarker-Guided Trials

TL;DR: A 2026 review in Neuropsychiatric Disease and Treatment argued that electroacupuncture (EA), acupuncture delivered with small electrical stimulation, has depression-related mechanism evidence, but clinical trials need biomarker-guided patient groups, standardized stimulation dose, and objective outcomes before EA can be treated as precision depression care. Key Findings Clinical evidence remains uneven: some randomized trials and …

Read more

Three Childhood ADHD Dimensions Each Predicted Distinct Adult Mood-Disorder Profiles in 755 Patients

by
Three Childhood ADHD Dimensions Each Predicted Distinct Adult Mood-Disorder Profiles in 755 Patients

TL;DR: A 2026 study in European Archives of Psychiatry and Clinical Neuroscience of 755 Korean adults with mood disorders found that three distinct childhood ADHD traits each tracked with different adult clinical features, suggesting ADHD’s influence on mood-disorder presentation is dimension-specific rather than uniform. Key Findings Mood-disorder profiles split by ADHD trait: Researchers analyzed 755 …

Read more

Arts on Prescription Helped Young Adults Rebuild Mental-Health Routines

by
Arts on Prescription Helped Young Adults Rebuild Mental-Health Routines

TL;DR: A 2026 qualitative study in iScience found that a 10-week Arts on Prescription program helped unemployed young adults with anxiety, depression, or stress report better mood, stronger routines, and less isolation, but some activities also caused stress, fatigue, or boundary concerns. Key Findings Young adult mental-health sample: The study focused on 22 Danish participants …

Read more

Antidepressant Side Effects in Pakistan Varied by Drug Class in 457 Adults With MDD

by
Antidepressant Side Effects in Pakistan Varied by Drug Class in 457 Adults With MDD

TL;DR: A 2026 study in Annals of General Psychiatry found that, among 457 adults with recurrent major depressive disorder in Pakistan, escitalopram was the most common single antidepressant and reported side effects varied sharply by drug class. Key Findings Clinic sample covered 457 adults: All participants had recurrent major depressive disorder and were recruited from …

Read more

tVNS Improved Reward-Effort Efficiency in Severe Depression Symptoms

by
tVNS Improved Reward-Effort Efficiency in Severe Depression Symptoms

TL;DR: A 2026 preprint on medRxiv tested transcutaneous vagus nerve stimulation (tVNS), a noninvasive ear-based stimulation method, during a grip-strength reward task and found that people with severe depressive symptoms made more efficient effort choices under active stimulation than under sham. Key Findings Reward-effort task included 98 participants: The analysis included 53 people with major …

Read more

Resistance Exercise Linked to Lower Depression and Anxiety Scores

by
Resistance Exercise Linked to Lower Depression and Anxiety Scores

TL;DR: A 2026 study in Journal of Korean Medical Science found that resistance exercise was more consistently associated with lower depression and anxiety scores than aerobic exercise in Korean adults, but the cross-sectional design means the study cannot prove exercise caused the mental-health difference. Key Findings Resistance exercise had the strongest association with lower Patient …

Read more

+ Load more